Visalytics
Visalytics
approved EB-2 (NIW)

Associate Research Scientist

Synthetic Organic Chemistry · India · 2025-02-24

Processing Time
296 days
Decision Date
2025-02-24
Location
Indiana
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop targeted cancer therapeutics and precision-based therapeutic options to prevent the recurrence of malignant diseases. The work focuses on creating cost-effective, personalized, and immunological therapies to simplify cancer diagnosis and treatment. The endeavor aims to improve treatment outcomes, reduce side effects, and lower long-term healthcare costs in the United States.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical cancer care improvements and pharmaceutical innovation which align with national healthcare priorities.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 9 publications and 84 citations demonstrates the influence and established expertise necessary to advance the field.

3 Balance of Interests Met

The practical value of the research in reducing long-term medical costs and advancing drug discovery makes it beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's scholarly impact, including 9 peer-reviewed journal articles (5 as first author) and 84 citations. Expert testimony confirmed the technical depth and practical application of the work for drug discovery. The case satisfied all three Dhanasar prongs by demonstrating the national significance of precision cancer care and the petitioner's established expertise.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions

Similar Cases

Physician

Biotechnology · China

WeGreened EB-2 (NIW) approved
27 days 2025-03-13
The petitioner proposes to focus on repurposing existing drugs for cancer treatment by leveraging advanced computational methods and bioinformatics tools. This work aims to enhance therapeutic options, improve patient outcomes, and significantly reduce the time and cost associated with traditional drug development.
View Case

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Missouri 49 days 2025-04-01
The petitioner proposes to identify novel therapeutic targets to improve personalized medicine and enhance treatment outcomes for cancer patients. Her work focuses on addressing drug resistance in oncology by integrating synthetic biology, protein engineering, and tumor signaling analysis to develop optimized drug delivery methods.
View Case

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved
California 467 days 2025-03-05
The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 296 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist